UNSPSC 51122406: Phenobarbital/sodium nitrite

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV250. This VA Drug Class (CV250) classifies this compound as belonging to the group ANTIANGINALS.

UNSPSC 51122406 Phenobarbital/sodium nitrite, a Commodity code, represents state and local procurement of emergency and clinical pharmaceuticals supplied to first-responder agencies and public health systems. The recent solicitations under this code show state and local governments buying Advanced Life Support medications, generic multi-source pharmaceuticals, and OTC products through competitive bidding and cooperative purchasing agreements. Issuing bodies include city fire rescue departments, state health agencies, and multistate cooperative purchasing alliances. The City of Tampa Fire Rescue, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the mix of local emergency-services buyers, state Medicaid and pharmacy-benefit administrators, and cooperative purchasing vehicles that characterize activity under the code. Work scopes range from single-award sealed-bid procurements for specific medication line items to statewide and multi-state RFP vehicles for generic pharmaceuticals distributed through authorized wholesalers.

Recent activity centers in Florida, Texas, and Minnesota. The City of Tampa issued IFB 26P00188 for Advanced Life Support Medications (Labetalol, Epinephrine, Adenosine, Diltiazem) with a response date of April 8, 2026 and estimated contract value of $40,000; the contract carries a one-year term with two optional one-year renewals plus unilateral extension rights, and designates a 5 percent bid discount for Small Local Business Enterprise participation not to exceed $10,000. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on direct contracting capacity outside traditional PBM, GPO, and wholesaler channels. MMCAP, administering a multistate cooperative through the Minnesota Department of Administration, issued RFP S1070000015802 due March 26, 2026 for generic multi-source pharmaceuticals and OTC products to be distributed through three authorized wholesalers (Cencora, Cardinal Health, Morris & Dickson) across participating state and local facilities in Minnesota and Oregon, with contract effectiveness July 1, 2026; the RFP weights price competitiveness at 75 percent and requires vendors to maintain relationships with at least two of the three authorized wholesalers.